Zobrazeno 1 - 4
of 4
pro vyhledávání: '"María Paula Del Medico Zajac"'
Autor:
María Paula Morelli, María Paula Del Medico Zajac, Joaquín Miguel Pellegrini, Nicolás Oscar Amiano, Nancy Liliana Tateosian, Gabriela Calamante, María Magdalena Gherardi, Verónica Edith García
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Mycobacterium tuberculosis (Mtb) infection is one of the leading causes of death worldwide. The Modified Vaccinia Ankara (MVA) vaccine vector expressing the mycobacterial antigen 85A (MVA85A) was demonstrated to be safe, although it did not improve B
Externí odkaz:
https://doaj.org/article/7553edbeb0a346fab78c0f7ff0d6f9ab
Autor:
María José Gravisaco, María Magdalena Gherardi, María Paula Del Medico Zajac, Gabriela Calamante, Gabriel Morón, Paula Molinari, Daniel Omar Maizon
Publikováno v:
Molecular immunology. 139
Modified vaccinia Ankara virus (MVA) is extensively used as a vaccine vector. We have previously observed that MVAΔ008, an MVA lacking the gene that codes for interleukin-18 binding protein, significantly increases CD8+ and CD4+ T-cell responses to
Publikováno v:
Frontiers in Veterinary Science, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/b0ccb6afe8e8490e8cae78d7f0e3148c
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.
Autor:
Juliana Falivene, María Paula Del Médico Zajac, María Fernanda Pascutti, Ana María Rodríguez, Cynthia Maeto, Beatriz Perdiguero, Carmen E Gómez, Mariano Esteban, Gabriela Calamante, María Magdalena Gherardi
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e32220 (2012)
BACKGROUND: Modified Vaccinia Ankara (MVA) is an attenuated strain of Vaccinia virus (VACV) currently employed in many clinical trials against HIV/AIDS and other diseases. MVA still retains genes involved in host immune response evasion, enabling its
Externí odkaz:
https://doaj.org/article/1bc24610786648a684aef0e331e57445